Early ERT Improves Pompe Disease Outcomes
source: shutterstock.com

Early ERT Improves Pompe Disease Outcomes

Enzyme replacement therapy (ERT) is an approved treatment strategy for those with Pompe disease. It involves providing patients with alpha-glucosidase, which helps to break down glycogen. In addition to reducing…

Continue Reading Early ERT Improves Pompe Disease Outcomes

World Alliance of Pituitary Organizations’ Webinar: Fighting Against the Global Issue of Substandard and Falsified (SF) Medical Products

  • Post author:
  • Post category:

Online Webinar: Fighting Against the Global Issue of Substandard (SF) and Falsified Medical Products With Dr. Bahijja Raimi-Abraham October 20, 2022 Dr Bahijja Raimi-Abraham is a pharmacist, Lecturer in Pharmaceutics…

Continue Reading World Alliance of Pituitary Organizations’ Webinar: Fighting Against the Global Issue of Substandard and Falsified (SF) Medical Products
Could AI Predict Vasculitis and Spondyloarthritis?
Rosser1954 / CC BY-SA (https://creativecommons.org/licenses/by-sa/4.0)

Could AI Predict Vasculitis and Spondyloarthritis?

It’s no secret that receiving a rare disease diagnosis can take excess amounts of time. Various articles share that, on average, it takes anywhere from four to nine years for…

Continue Reading Could AI Predict Vasculitis and Spondyloarthritis?
RDLA Webinar: Updates on the VALID Act, RUSP Alignment, Newborn Screening, and Precision Medicine for Kids
source: shutterstock.com

RDLA Webinar: Updates on the VALID Act, RUSP Alignment, Newborn Screening, and Precision Medicine for Kids

On September 28, 2022, the Rare Disease Legislative Advocates (RDLA) hosted their monthly webinar. These webinar help provide updates to the rare disease community on legislation and other policy initiatives…

Continue Reading RDLA Webinar: Updates on the VALID Act, RUSP Alignment, Newborn Screening, and Precision Medicine for Kids
How “My Rare ID” Supports the Rare Disease Community: An Interview with Jeff Lord (Pt. 2)
My Rare ID logo

How “My Rare ID” Supports the Rare Disease Community: An Interview with Jeff Lord (Pt. 2)

Before you continue, make sure you've read Part 1 of our interview, where we discussed the Lord family's story and experience with rare disease, and the development of MobiMedQR. This tool, which…

Continue Reading How “My Rare ID” Supports the Rare Disease Community: An Interview with Jeff Lord (Pt. 2)

Danny’s Dose’s Family Education Event: Hot Springs, AR

  • Post author:
  • Post category:

Danny's Dose Family Education Event: Hot Springs, AR October 1, 2022 EDUCATION:  Learn the "STEPS TO PROTECTION"  for proper EMERGENCY PREPAREDNESS,  "TREATMENT PLANS", working with your EMS/ER Staff, your existing…

Continue Reading Danny’s Dose’s Family Education Event: Hot Springs, AR
Researchers Unearth Potential Therapy for FBXL4 Mitochondrial Disease
Source: Pixabay

Researchers Unearth Potential Therapy for FBXL4 Mitochondrial Disease

FBXL4-related mitochondrial disease urgently requires new therapies. Unfortunately, this condition is often fatal by early ages (early to mid-childhood). Therefore, it is important to spur research into potential interventions or…

Continue Reading Researchers Unearth Potential Therapy for FBXL4 Mitochondrial Disease